Class / Patent application number | Description | Number of patent applications / Date published |
600034000 | Embryo transplantation | 80 |
20080200752 | Method for intrauterine embryo transfer and relevant device - The invention relates to method and a device for the intrauterine embryo transfer, according to a procedure in which the embryos are aspirated from a culture medium for being ejected into the uterine cavity, wherein the aspiration and the release of the embryos is realized using a catheter having a substantially constant inner diameter in which is inserted a relevant plunger. | 08-21-2008 |
20080300450 | Embryo development and survival - An embryo that is transferred into the uterus of a recipient female is protected from toxic effects of prostaglandin F | 12-04-2008 |
20090012352 | RECOVERABLE INTRA-UTERINE DEVICE - A recoverable intra-uterine device comprising a housing containing one or several elements selected from a group containing an embryo, male and/or female gametes, a fertilised oocyte, an unfertilised egg and the combination thereof, wherein said housing is provided with a wall made of a biocompatible material. The wall is provided with a series of perforations whose size is sufficient in order to bring the intra-uterine medium into a cellular contact with the housing and to keep the elements therein. The inventive device is provided with a system for loading and unloading one or several elements selected from the group containing an embryo, male and/or female gametes, a fertilised oocyte, an unfertilised egg and the combination thereof. | 01-08-2009 |
20090187068 | DEVICE FOR SAMPLE TAKING OR TRANSFER IN GENITAL ORGANS WITH AN IMPROVED ULTRASOUND VISIBILITY - A device whose main part is a catheter or probe which is advantageously made up by an echogenic tube on its whole length, and which is proportionally transparent. The structure is made up by a material chosen from among the group comprising amorphous thermoplastic polymer matrices incorporating a braid, strand or strip with a non metal echogenic material which is biocompatible and chosen from among filled or un-filled semi-crystalline thermoplastic polymers. | 07-23-2009 |
20090253952 | Methods and Compositions for Improved Fertilization and Embryonic Survival - Single nucleotide polymorphic sites at positions 3117, 12195, 13244, 13319, and 13516 of the bovine STAT5 gene are associated with improved fertilization rate and/or improved embryo survival rate. Also disclosed are nucleic acid molecules, kits, methods of genotyping and marker assisted bovine breeding methods. | 10-08-2009 |
20090292162 | Non-surgical embryo transfer method and apparatus - A device having a catheter and a hub which facilitates the transfer of an embryo containing solution into the uterus of a mammal, for example, a small mammal such as a rat or mouse. The catheter's shape and tip is designed to simplify insertion and minimize injury to the mammal. The hub is designed to further control the insertion of the catheter and to interface with a pipette, for example, that provides the force required for the transfer of an embryo containing solution. As a result, the transfer can occur without requiring surgery. | 11-26-2009 |
20090299129 | RECOVERABLE INTRA-UTERINE SYSTEM - The recoverable intra-uterine system comprises a housing capable of containing one or a plurality of elements selected from among the group comprising an embryo, male and/or female gametes, a fertilized oocyte, and unfertilized ovum and a combination of these elements, the housing having along an axis a distal end and a proximal end, and a device for holding the recoverable intra-uterine device in the uterus. The holding device is arranged at the proximal end of the housing and includes at least one holding arm in the uterine cavity capable of taking at least two positions: —one free position in which at least one holding arm is separated from the axis; and —a retracted position in which at least one holding arm is substantially parallel to the axis. Use in medically assisted reproduction techniques. | 12-03-2009 |
20090299130 | METHODS AND COMPOSITIONS FOR IMPROVED FERTILIZATION AND EMBRYONIC SURVIAL - Single nucleotide polymorphic site at position 11646 of the bovine FGF2 gene is associated with improved fertilization rate and/or improved embryo survival rate, as well as improved milk production. Also disclosed are nucleic acid molecules, kits, methods of genotyping and marker assisted bovine breeding methods. | 12-03-2009 |
20090312596 | ASSAY AND KIT FOR PREDICTING IMPLANTATION SUCCESS IN ASSISTED FERTILISATION - The present invention relates to an assay for determining the implantation potential of a plurality of embryos each obtained or to be obtained by assisted fertilisation of an oocyte of a female subject, comprising measuring the levels of granulocyte-colony stimulating factor (G-CSF) in the follicular fluid (FF) present in the follicle from which each oocyte is derived, and determining the implantation potential of each embryo from the level of measured FF G-CSF. It also relates to a kit for carrying out the assay. It further relates to a method for assisted fertilisation. | 12-17-2009 |
20100016654 | Methods of Minimizing Immunological Rejection of A Nuclear Transfer Fetus - The present invention relates to a method of minimizing immunological rejection of a nuclear transfer (“NT”) fetus which includes transferring a NT embryo into an embryo recipient under conditions effective for development of a NT fetus with minimal risk of immunological rejection of the fetus due to a maternal anti-fetal MHC-I immune response. After determining an MHC-I antigen type for a NT embryo and an MHC-I antigen type for embryo recipients, the NT embryo is either (i) transferred into a first embryo recipient having a compatible MHC-I antigen type under conditions effective for development of a NT fetus from the NT embryo, or (ii) transferred into a second embryo recipient having an incompatible MHC-I antigen type, followed by regulating MHC-I expression of the NT embryo or suppressing an immune response of the embryo recipient under conditions effective for development of a nuclear transfer fetus. | 01-21-2010 |
20100036193 | Method of Embryo Transfer that Eliminates Transferred Air While Hormonally Inducing Implantation and Apparatus - A method of embryo transfer (“ET”) that improves fertility rates by eliminating transferred air during the procedure is provided. Also provided is a method for hormonally enhancing the uterine wall of a patient either prior to or during the time of ET. Quantitative administration of transfer solutions is accomplished with a modified apparatus that provides for implantation of an embryo into the uterus of a patient. The apparatus comprises an outer sheath and an inner lumen arranged to be slidably disposed within the outer sheath. The inner lumen includes at least one visual marker situated on the exterior surface adjacent its distal end thereof. | 02-11-2010 |
20100160717 | In vitro fertilization - Methods of in vitro fertilization wherein said method includes preimplantation genetic diagnosis of all 24 chromosomes of an IVF embryo comprising whole genome amplification and SNP-based microarray analyses are disclosed. | 06-24-2010 |
20100185047 | Methods and Compositions for Testing and Breeding Cattle for Improved Fertility and Embryonic Survival - Disclosed are arrays of nucleic acid molecules, kits, methods of genotyping and marker assisted bovine breeding methods using SNPs on genes of the bovine interferon tau signaling pathway for improved bovine fertilization rate, or embryo survival, or both. | 07-22-2010 |
20110009689 | ASSAY OF NITRIC OXIDE METABOLITES IN THE CULTURE MEDIA OF HUMAN PREIMPLANTATION EMBRYOS - The present invention relates, e.g., to a method for predicting the embryonic progression of a preimplantation embryo, comprising measuring in the insemination medium (IM) in which an oocyte was fertilized and subsequently incubated in vitro, thereby generating a pre-implantation embryo, at 18-24 hrs post fertilization, the levels of nitric oxide metabolites (NOx) in the insemination medium (IM), wherein a level of NOx of at least about 1.3 μM indicates that the preimplantation embryo is likely to progress to the blastocyst stage by culture day (CD) 5. | 01-13-2011 |
20110054246 | WHOLE GENOME SCAN TO DISCOVER QUANTITATIVE TRAI LOCI (QTL) AFFECTING GROWTH, BODY COMPOSITION, AND REPRODUCTION IN MATERNAL PIG LINES - The present invention provides compositions and methods useful for determining an animal's genotype and to select animals having a desired genotype. Embodiments of the invention also provide isolated nucleic acid molecules and analytical kits that may be used to determine an animal's genotype. Furthermore, the present invention provides methods for improving desirable animal traits including improved growth, enhanced body composition, and improved reproductive traits. The invention also provides methods for allocating animals for predetermined uses, for picking potential parent animals for breeding, and for producing progeny animals. The instant invention also provides methods for identifying associations between single nucleotide polymorphisms (SNPs) and phenotypic traits. Also provided are methods for identifying genetic markers in allelic association with the SNP disclosed herein and for identifying the genotypes of a causative mutation underlying a quantitative trait locus (QTL). | 03-03-2011 |
20110054247 | METHODS FOR CLONING FERRETS AND TRANSGENIC FERRET MODELS FOR DISEASES - The invention provides a transgenic Mustelidae in which a gene associated with a human disease or condition comprises a targeted genetic modification, and uses thereof. Also provided is a method to cryopreserve Mustelidae embryos or cells, and to enhance the number of live offspring from cryopreserved Mustelidae embryos. | 03-03-2011 |
20110092762 | IMAGING AND EVALUATING EMBRYOS, OOCYTES, AND STEM CELLS - Methods, compositions and kits for determining the developmental potential of one or more embryos or pluripotent cells and/or the presence of chromosomal abnormalities in one or more embryos or pluripotent cells are provided. These methods, compositions and kits find use in identifying embryos and oocytes in vitro that are most useful in treating infertility in humans. | 04-21-2011 |
20110092763 | Methods for Embryo Characterization and Comparison - Disclosed herein are methods for determining which embryos from a group of embryos are most likely to implant and develop as desired. In an embodiment of the present disclosure, one or more cells are biopsied from each of the embryos, and the genetic condition of those cells are determined. Within a group of embryos that each test positive for aneuploidy, the likelihood that each embryo contains euploid cells may be determined from the type of aneuploidy observed in the biopsied cells. This knowledge may be used to make a decision as to which embryos to transfer to a uterus. In an embodiment of the present disclosure, these determinations are made for the purpose of embryo selection in the context of in vitro fertilization. | 04-21-2011 |
20110098524 | COLLECTOR DEVICE FOR CATTLE EMBRYOS - The present invention relates to an embryos collector system used for the collection and careful selection of embryos, which maintains the fluid control from the uterus discharge fluids inside the collector device and the control of displacement of the embryos and mucosal in the interior of the device. This system includes a conduit system free of internal collision points where the embryos can safely navigate to a section on the device, in which the direction, force, and speed of the turbulent currents are controlled; thus, the embryos are not subjected to any trauma, cannot be trapped by the mucosal; nor dragged by the filtration mesh. | 04-28-2011 |
20110105834 | IMAGING AND EVALUATING EMBRYOS, OOCYTES, AND STEM CELLS - Methods, compositions and kits for determining the developmental potential of one or more embryos or pluripotent cells and/or the presence of chromosomal abnormalities in one or more embryos or pluripotent cells are provided. These methods, compositions and kits find use in identifying embryos and oocytes in vitro that are most useful in treating infertility in humans. | 05-05-2011 |
20110118539 | ASSOCIATION OF THE PROGESTERONE RECEPTOR WITH FERTILITY - A single nucleotide polymorphic site at position 59752 of the bovine PGR gene is associated with improved fertilization rate or early embryo survival. Disclosed are nucleic acid molecules, kits, methods of genotyping and marker assisted bovine breeding methods. | 05-19-2011 |
20110172488 | Medico-surgical devices - An embryo replacement catheter has a flexible extruded shaft of a transparent polyurethane with a bore extending along its length. Gas bubbles of a diameter in the range 5μ to 10μ are incorporated into the thickness of the wall of the shaft by adding gas during extrusion. The bubbles are selected to increase the visibility of the catheter under ultrasound imaging whilst still enabling material flowing along the catheter to be seen. | 07-14-2011 |
20110213198 | HIGH-THROUGHPUT AND NON-INVASIVE METHOD TO VITRIFY PORCINE EMBRYOS - The present invention provides a practical, non-invasive, and efficient method for cryopreservation of an in-vitro-produced porcine embryo. The inventive method treats the NP (such as IVF- or NT-derived) embryo at the one-cell or cleavage stage prior to compaction with high osmolality followed by high speed centrifugation. The high osmolality treatment enlarges the periviteline space, and with centrifugation, enables the separation of the lipids from the cytoplasm. The lipid-separated embryos after high osmolality treatment have been successfully cryopreserved and later recovered and transferred to produce live offspring. | 09-01-2011 |
20110245592 | Secretome Profile-Facilitated In Vitro Fertilization - Secretome profiling improves the pregnancy success rate of in vitro fertilization processes, while reducing the risk of multiple births. | 10-06-2011 |
20110275885 | RECOVERABLE INTRA-UTERINE SYSTEM - A recoverable intra-uterine system comprises a receptacle ( | 11-10-2011 |
20120095286 | CATHETER FOR AN EMBRYO TRANSFER AND A CARRIER FOR A CELL TRANSPORT - A catheter for introduction, particularly of the embryos, comprising an aspirator combined with an inner part of the catheter, characterized in that the core of the catheter is placed ( | 04-19-2012 |
20120095287 | IMAGING AND EVALUATING EMBRYOS, OOCYTES, AND STEM CELLS - Methods, compositions and kits for determining the developmental potential of one or more embryos or pluripotent cells and/or the presence of chromosomal abnormalities in one or more embryos or pluripotent cells are provided. These methods, compositions and kits find use in identifying embryos and oocytes in vitro that are most useful in treating infertility in humans. | 04-19-2012 |
20120123193 | METHOD OF ASSESSING EMBRYO OUTCOME - Non-invasive methods of predicting embryo outcome by analyzing disclosed markers in embryo culture media. | 05-17-2012 |
20120172660 | Catheter, In Particular for Implanting an Embryo in the Uterine Cavity of a Human Being or Animal, and Corresponding Instrument - This catheter ( | 07-05-2012 |
20130006047 | METHOD FOR IDENTIFYING A MAMMAL RECEPTIVE TO EMBRYO TRANSFER - The present invention is drawn to novel methods of selecting mammals receptive to embryo transfers in order to improve reproductive efficiency and milk production of the mammals. The present invention encompasses three methods: (1) selecting from any group of mammals; (2) selecting from estrus-negative mammals; and (3) selecting from estrus-negative mammals and pooling the selected mammals with estrus-positive mammals. Also encompassed is a kit for selecting mammals receptive to embryo transfers. | 01-03-2013 |
20130023726 | FERTILITY AGENT - Means for improving the success rate of pregnancy on the basis of blastocyst transfer is disclosed. The means comprises an agent for promoting pregnancy in blastocyst transfer comprising the supernatant of the culture which is obtained by culturing a human embryo in a medium until the embryo develops into a blastocyst. Also disclosed are a method for production of the agent, as well as a method for promoting pregnancy comprising; culturing a human embryo in a medium until the human embryo develops into a blastocyst, injecting a composition comprising the supernatant of the culture into the uterine cavity of a patient who is to undergo blastocyst transfer, and then transferring the blastocyst to the recipient. | 01-24-2013 |
20130053628 | METHOD FOR CULTIVATING A TRANSGENIC ANIMAL WITH INCREASED EXPRESSION AMOUNT OF PORCINE GROWTH HORMONE - A method for cultivating a transgenic animal with an increased expression amount of porcine growth hormone is provided. Additionally, a method for cultivating a transgenic embryo, which introduces a recombinant expression vector of 1) TRE-GH or 2) TET-ON into a target embryo to obtain a transgenic embryo with a higher expression amount of porcine growth hormone than a target embryo without introduction is provided. A transgenic animal can be obtained by transplanting the embryo into an animal. The experiments demonstrate that growth hormone (GH) is sharply increased in blood of transgenic pigs after adding DOX. | 02-28-2013 |
20130072748 | METHODS FOR ASSESSING ENDOMETRIUM RECEPTIVITY OF A PATIENT - The present invention relates to a method for assessing the endometrium receptivity of a patient, comprising a step consisting of measuring the expression level of eleven genes in an endometrial biopsy sample obtained from said patient wherein said genes are MFAP5, ANGPTL1, PROK1, NLF2, LAMB3, BCL2L10, CD68, TRPC4, SORCS1, FST and KRT80. | 03-21-2013 |
20130096370 | COMPOSITIONS AND SYSTEMS FOR THE REGULATION OF GENES - The present invention provides compositions and methods of modulating or regulating eukaryotic gene expression through the controlled or regulated expression of polynucleotide constructs that encode siRNA or other desired exogenous nucleic acids or proteins. Such constructs, and additional elements of the system may be transfected into the cells of interest and the expression of the siRNA, and hence the expression of the target gene of the siRNA, may be controlled through the administration of a compound to the cell, such as a small molecule or drug. Lentivirus vectors are employed in some embodiments of the invention including the generation of conditional knockdown animals. | 04-18-2013 |
20130102837 | EMBRYO QUALITY ASSESSMENT BASED ON BLASTOMERE DIVISION AND MOVEMENT - The invention concerns a system and method for determining embryo quality comprising monitoring the embryo for a time period, said time period having a length sufficient to comprise at least one cell division period and at least a part of an inter-division period, and determining the length of the at least one cell division period; and/or ii) determining the extent and/or spatial distribution of cellular or organelle movement during the cell division period; and/or iii) determining duration of an inter-division period; and/or iv) determining the extent and/or spatial distribution of cellular or organelle movement during the inter-division period thereby obtaining an embryo quality measure. Thus, the selection of optimal embryos to be implanted after in vitro fertilization (IVF) is facilitated based on the timing, duration, spatial distribution, and extent of observed cell divisions and associated cellular and organelle movement. | 04-25-2013 |
20130102838 | Oocyte Spindle-Associated Factors Improve Somatic Cell Cloning - The invention pertains to the discovery that the presence of oocyte spindle associated factors in an enucleated oocyte improves oocyte quality and subsequently nuclear transfer. In particular, it was discovered that maintaining oocyte spindle factors in the oocyte after enucleation improves oocyte quality for use in nuclear transfer methodology. | 04-25-2013 |
20130116499 | METHOD FOR PRODUCING EMBRYOS BY IN VITRO CULTURE, AND METHOD, APPARATUS, AND SYSTEM FOR SELECTING EMBRYOS - An object of the present invention is to provide a means for efficiently obtaining mammalian embryos having high conception rates. A first aspect of the present invention is a method for selecting a mammalian embryo prepared by in vitro culture from a fertilized egg, comprising a step of selecting an embryo using two or more of the following indicators: the time from fertilization to the completion of first cleavage; the morphology at a stage after first cleavage and before second cleavage; the morphology at a stage after third cleavage and before fourth cleavage; and the amount of oxygen consumed at the early blastocyst stage, the blastocyst stage, or the expanded blastocyst stage. | 05-09-2013 |
20130144114 | DIAGNOSTIC METHOD FOR ENDOMETRIAL RECEPTIVITY - The invention relates to a non-invasive diagnostic method of endometrial receptivity which includes collecting and comparing lipid biomarker patterns to reference lipidomic biomarkers, particularly prostaglandins PGE2 and/or PGF2α. The method is especially applicable for determining status fertility of a mammalian female, preferably, a woman. | 06-06-2013 |
20130165744 | Recovery and processing of human embryos formed in vivo - Among other things, uterine lavage is performed to withdraw at least 50% of in vivo fertilized preimplantation embryos produced after superovulation of a woman and artificial insemination using sperm of her sexual partner. After genetic diagnosis or sex determination or gene therapy, or any combination of any two or more of them, of the recovered embryos and selection of at least one of the embryos to be implanted, the selected embryos are returned to the woman for implantation in her uterus. | 06-27-2013 |
20130165745 | IMAGING AND EVALUATING EMBRYOS, OOCYTES, AND STEM CELLS - Methods, compositions and kits for determining the developmental potential of one or more embryos or pluripotent cells and/or the presence of chromosomal abnormalities in one or more embryos or pluripotent cells are provided. These methods, compositions and kits find use in identifying embryos and oocytes in vitro that are most useful in treating infertility in humans. | 06-27-2013 |
20130172666 | METHOD OF IN VITRO FERTILIZATION WITH DELAY OF EMBRYO TRANSFER AND USE OF PERIPHERAL BLOOD MONONUCLEAR CELLS - A method of in vitro fertilization wherein the embryo is implanted into the uterus of a female patient at least two, and preferably three to twelve months after the eggs are retrieved from the patient in order to reduce the effect of autoimmune rejection of the embryo by the patient's autoimmune system and increase the probability and success of pregnancy and wherein prior to embryo implantation, the endometrium in the uterus is prepared for embryo implantation by introducing peripheral blood mononuclear cells (PBMCs) into the uterus. The procedure is combined with cryopreservation techniques to preserve the oocytes or the IVF-produced embryos of the patient. | 07-04-2013 |
20130184518 | MECHANICAL BIOMARKERS FOR OOCYTE AND EMBRYO VIABILITY - Provided are methods for the determination of the viability of a mammalian embryo or a potential embryo generated from a mammalian oocyte, comprising applying a mechanical stimulus to the embryo or oocyte, detecting a temporal response of the embryo or oocyte to the mechanical stimulus, and deriving measurements for one or more parameters from the temporal response, the measurements being indicative of viability. Also provided are methods for selecting an embryo for transfer and methods for enhancing the viability of an embryo or oocyte. | 07-18-2013 |
20130211187 | Method of Establishing Mouse Strain - A method of producing a chimera animal, characterized by transplanting, into a host animal, an aggregate of a first pluripotent stem cell that is of interest to strain establishment, a second pluripotent stem cell in which the ability to form germ cells is absent or decreased, and embryo. | 08-15-2013 |
20130225917 | EMBRYO QUALITY ASSESSMENT BASED ON BLASTOMERE DIVISION AND MOVEMENT - The invention concerns a system and method for determining embryo quality comprising monitoring the embryo for a time period, said time period having a length sufficient to comprise at least one cell division period and at least a part of an inter-division period, and determining the length of the at least one cell division period; and/or ii) determining the extent and/or spatial distribution of cellular or organelle movement during the cell division period; and/or iii) determining duration of an inter-division period; and/or iv) determining the extent and/or spatial distribution of cellular or organelle movement during the inter-division period thereby obtaining an embryo quality measure. Thus, the selection of optimal embryos to be implanted after in vitro fertilization (IVF) is facilitated based on the timing, duration, spatial distribution, and extent of observed cell divisions and associated cellular and organelle movement. | 08-29-2013 |
20140128667 | ADAPTIVE EMBRYO SELECTION CRITERIA OPTIMIZED THROUGH ITERATIVE CUSTOMIZATION AND COLLABORATION - The present invention relates to a system and a method for determining quality criteria in order to select the most viable embryos after in vitro fertilization. The present invention may further be applied for iteratively adapting embryo quality criteria based on new knowledge, historical selection & fertilization data and cooperation between fertility clinics. | 05-08-2014 |
20140142369 | DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE - Nucleic acid molecules comprising a SNP site at position 1296 of bovine uterine milk protein (UTMP) coding sequence (SEQ ID NO: 1), which SNP indicates a desirable productive life in a dairy cattle. Also disclosed are an array or a kit comprising the same, a method for detecting the SNPs, a method for progeny testing of cattle, and a method for selectively breeding of cattle. | 05-22-2014 |
20140155689 | METHODS OF MODIFYING GENES IN EUKARYOTIC CELLS - Methods of creating mutations in genomic exons by inserting introns into the genomic exons via homologous recombination. Also, methods are provided for introducing modifications into genomic exons by inserting introns into the genomic exons via homologous recombination such that a mature mRNA transcript produced from a genomic region of the genome comprising the genomic exon does not contain the modification are provided. The methods provide for a rapid method for introducing mutations and/or modifications of any type into a mammalian cell genome. | 06-05-2014 |
20140163313 | Sonography Guided Embryo Transfer For In Vitro Fertilization - The present provides novel systems and methods to facilitate embryo transfer, to maximize implantation rates and to improve pregnancy rates resulting from In Vitro fertilization. | 06-12-2014 |
20140179988 | Embryo Transfer - An embryo from a female animal is transferred to another animal by determining presence of an embryo in the uterus of a donor animal by ultra-sonic imaging and inserting an endoscope vaginally into the uterus to a location adjacent the embryo. A tool of the endoscope projects to a position to extract the embryo washed into a container of the tool which is then closed by moving a closure part to enclose the embryo and extracting the endoscope to remove the embryo for transfer to a recipient animal. The fluid into the container can be controlled in pressure to maintain a required pressure generally matching that inside the uterus. | 06-26-2014 |
20140200393 | METHODS AND COMPOSITIONS FOR MONITORING AND ENHANCING EARLY EMBRYO DEVELOPMENT - Method for determining developmental fate of early embryos comprises measuring the expression level of a gene selected from the group consisting of CDKN1C, IGF2R, MAGEL2, MKRN3, NAP1L5, NDN, PEG3, PHLDA2, TSSC4, and UBE3A genes. Also disclosed is a method for improving pregnancy rate, wherein early embryos whose expression level of the MKRN3, NDN, PEG3, PHLDA2, TSSC4, or UBE3A gene is not increased, or the expression level of the CDKN1C, IGF2R, MAGEL2, or NAP1L5 gene is not decreased, are selected for planting into a suitable uterus for further development. Also disclosed are methods for increasing the likelihood of an early embryo to develop successfully into full-term pregnancy, wherein a suitable amount of siRNA corresponding to the PHLDA2 gene is injected into a fertilized egg which is in turn cultured further and planted into a suitable uterus. | 07-17-2014 |
20140200394 | Method to select animals with a high capacity of embryo production - The present invention provides a method to select a non-human female animal subject having the capacity to produce appropriate number of transferable embryos or fertilizable oocytes in said animal, said method comprising the determination of the anti-Mullerian hormone concentration in a biological sample before an ovarian superovulatory treatment. The present invention is further directed to the use of AMH as a predictive marker of number of transferable embryos or fertilizable oocytes able to be produced in a non-human female animal. | 07-17-2014 |
20140206931 | Methods For Predicting Mammalian Embryo Viability - The invention provides methods and systems for assessing the developmental potential of mammalian embryos. The method of the invention comprises taking measurements of cytoplasmic movements in the embryo and/or periodic changes in the shape of the embryo at the single cell stage. | 07-24-2014 |
20140221734 | CLONED NON-HUMAN ANIMALS FREE OF SELECTIVE MARKERS - Genetically modified somatic cells of a non-human animal are provided that are engineered to contain a self-excisable, recombinase expression cassette comprising a site-specific recombinase gene operably linked to an ES cell-specific promoter. Compositions and methods for producing a genetically modified, cloned non-human animal that is free of a selective marker gene and a recombinase gene are provided, wherein a targeting construct comprising a self-excisable recombinase gene operably linked to an ES cell-specific promoter is introduced into differentiated somatic cells. The genetically modified genome of the somatic cells is transferred into an enucleated host oocyte. The artificially created zygote is then cultured in vitro until the blastocyst embryonic stage and subsequently implanted into a uterus of a surrogate mother to form a genetically modified, cloned non-human animal free of selective marker and recombinase genes. | 08-07-2014 |
20140221735 | Nondestructive means of ectopic pregnancy management - In a non-destructive means of ectopic pregnancy management, a baby is delivered with the gestational sac intact and then submerged in an incubator containing ventilating fluid; the baby is placed in an absorbable transfer capsule and transcervically transferred to the uterine cavity; the capsule dissolves after a period of time to leave the gestational sac abutted to the endometrium so the baby can reattach. To maintain the baby's life support, the means includes fluidic ventilators and ventilation catheters to perfuse the gestational sac with ventilating fluid during such times as delivery, incubation, transfer, and reimplantation. Advantageously, the transfer capsule protects the baby during transfer and serves as a convenient vehicle for placing devices such as the ventilation catheter in the uterus along with the baby. An exemplary transfer capsule is flexible like a soft contact lens; hydrates with a solution containing nutrients and factors to promote the biomechanical interactions of implantation; and, being based on a hyaluronan hydrogel, dissolves in the uterine cavity to provide the baby and mother with hyaluronan which is known to benefit implantation. Hard shell absorbable transfer capsules are also provided for when structural support is needed. | 08-07-2014 |
20140235933 | GENETIC MODIFICATION OF RATS - Compositions and methods are provided for making rat pluripotent and totipotent cells, including rat embryonic stem (ES) cells. Compositions and methods for improving efficiency or frequency of germline transmission of genetic modifications in rats are provided. Such methods and compositions comprise an in vitro culture comprising a feeder cell layer and a population of rat ES cells or a rat ES cell line, wherein the in vitro culture conditions maintain pluripotency of the ES cell and comprises a media having mouse leukemia inhibitor factor (LIF) or an active variant or fragment thereof. Various methods of establishing such rat ES cell lines are further provided. Methods of selecting genetically modified rat ES cells are also provided, along with various methods to generate a transgenic rat from the genetically modified rat ES cells provided herein. Various kits and articles of manufacture are further provided. | 08-21-2014 |
20140243585 | SCREENING OF OOCYTE DONOR CANDIDATES BASED ON THE FMR1 GENE - Method of selecting oocyte donor candidates for oocyte donation. A number of triple CGG repeats on each allele of the isolated FMR1 gene is measured by using an assay, and an oocyte donor is selected for oocyte donation only if both alleles of the isolated FMR1 gene have more than 26 CGG repeats. | 08-28-2014 |
20140249363 | METHOD FOR EVALUATING HUMAN BLASTOCYST BY NOREPINEPHRINE LEVEL IN BLASTOCYST CULTURE SOLUTION - The invention provides a new method for evaluating transfer embryos including blastocysts used for in vitro fertilization in fertility treatment, and a method for evaluating transfer embryos using a new biomarker necessary for evaluation. The method comprises the steps of (a) providing a test object, for example, a culture solution of a human blastocyst, containing norepinephrine (noradrenaline) released from a transfer embryo, such as a human blastocyst, obtained from a subject; (b) quantitatively analyzing norepinephrine in the test object by a combination of ultra high performance liquid chromatography and mass spectrometry or the like; (c) predicting the quality of the transfer embryo based on the amount of norepinephrine from analysis results obtained; and (d) transferring the embryo into a suitable female recipient for implantation, if the transfer embryo is predicted to be of good quality and/or to lead to the establishment of a viable pregnancy based on step (c). | 09-04-2014 |
20140249364 | OOCYTES DERIVED FROM OVARIAN CULTURE INITIALLY CONTAINING NO OOCYTES - Ovarian germ-line-competent embryonic stem cells (GLC-ESC) are cultured, either in the presence or absence of a compound having estrogenic activity. The GLC-ESC are either collected prior to specific commitment or are permitted to remain in the culture medium for a time sufficient to develop into oocytes, and the oocytes may be fertilized by adding sperm to the culture medium. The fertilized oocytes may be permitted to develop into embryos, which may be transferred into the uterus of an adult human female or frozen for later use. The invention provides a method for obtaining by in vitro fertilization an embryo that is genetically related to a human female who is not producing oocytes. | 09-04-2014 |
20140309487 | TARGETED MODIFICATION OF RAT GENOME - Compositions and methods are provided for modifying a rat genomic locus of interest using a large targeting vector (LTVEC) comprising various endogenous or exogenous nucleic acid sequences as described herein. Compositions and methods for generating a genetically modified rat comprising one or more targeted genetic modifications in their germline are also provided. Compositions and methods are provided which comprise a genetically modified rat or rat cell comprising a targeted genetic modification in the rat interleukin-2 receptor gamma locus, the rat ApoE locus, the rat Rag2 locus, the rat Rag1 locus and/or the rat Rag2/Rag1 locus. The various methods and compositions provided herein allows for these modified loci to be transmitted through the germline. | 10-16-2014 |
20140378754 | UTERINE EMBRYO RETRIEVAL - A device for recovering one or more blastocysts from a uterus of a human includes an outer guide member for insertion into a cervical canal of the human. The outer guide member includes a distal portion with an activatable seal for isolating the uterus from the external environment. The outer guide member defines a lumen having a longitudinal axis. The device also includes an inner catheter located within the lumen and slidable along the longitudinal axis of the lumen relative to the outer guide member. The inner catheter has a distal tip positionable distally of the seal to extend into the uterus. The distal tip includes a semi-permeable absorbent head. The device defines a distal suction port for aspirating blastocysts from the uterus through the absorbent head. | 12-25-2014 |
20140378755 | RAPID BREEDING OF ANIMALS - Various embodiments disclosed herein include systems, methods, compositions, and products by process for in vitro cycling of gametes for rapid breeding of animals. In certain embodiments, the systems and/or methods are at least partially automated. | 12-25-2014 |
20140378756 | UTERINE LAVAGE FOR EMBRYO RETRIEVAL - A device for recovering one or more blastocysts from the uterus of a human includes an outer guide member for insertion into a cervical canal of the human. The outer guide member includes a distal portion with an activatable seal for isolating the uterus from the external environment and defines a lumen having a longitudinal axis. The device also includes an inner catheter located within the lumen and slidable along the longitudinal axis of the lumen relative to the outer guide member. The inner catheter has a distal tip positionable distally of the seal to extend into the uterus and includes a fluid delivery lumen terminating at a distal fluid delivery port for delivering fluid into the uterus. The device defines a distal suction port for aspirating fluid and entrained blastocysts from the uterus. The distal fluid delivery port and the distal suction port are arranged such that, in use, fluid delivered from the distal fluid delivery port travels through the distal suction port to the uterus. | 12-25-2014 |
20150025307 | DEVICE USED IN THE CONTEXT OF A GYNECOLOGICAL TRANSFER AND THE MANUFACTURE OF SUCH A DEVICE - This invention concerns a device for gynaecological transfer or insemination with shape memory comprising a catheter comprising a polymer tube open at its ends, characterised in that this tube is comprised of a medium-density polymer associated with mineral filler. | 01-22-2015 |
20150038778 | ITIH5 AS A DIAGNOSTIC MARKER OF UTERINE DEVELOPMENT AND FUNCTIONAL DEFECTS - The invention relates to the use of ITIH5 as a biomarker of endometrium receptivity to embryo implantation. Also provided are methods and kits for using this biomarker for detecting the receptivity state of the endometrium of a mammal to embryo implantation, for diagnosing infertility in a female mammal, for the early diagnosis of pregnancy, for detecting the window of embryo implantation in the endometrium of a female mammal, for in vitrofertilization of a female mammal, and for diagnosing endometriosis. | 02-05-2015 |
20150094524 | COMPOSITIONS AND METHODS FOR THE DETECTION OF ZINC - The invention relates generally to compositions and methods for the detection of zinc. In particular, compositions and methods are provided to detect changes in cellular zinc concentration and to correlate them to cellular phenomena. | 04-02-2015 |
20150305774 | IN VITRO PLATFORM AND METHODS FOR CULTURING EMBRYOS FOR IMPLANTATION - A mammalian in vitro system for culturing an embryo includes a collagen or fibrin matrix and endometrial and/or stromal cells. The in vitro platforms and methods according to embodiments of the invention allow for in vitro embryonic development (including implantation) prior to transfer of the embryo complex in vivo for further development. | 10-29-2015 |
20150307943 | SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH BULL FERTILITY - Single nucleotide polymorphic sites of the bovine MAP1B, PPP1R11, and DDX4 genes are associated with improved bull fertility as measured by e.g. sire conception rates. Nucleic acid molecules, arrays, kits, methods of genotyping and marker-assisted bovine breeding methods based on these SNPs are disclosed. | 10-29-2015 |
20150313639 | METHOD OF EMBRYO TRANSFER THAT ELIMINATES TRANSFERRED AIR WHILE HORMONALLY INDUCING IMPLANTATION AND APPARATUS - A method of embryo transfer (“ET”) that improves fertility rates by eliminating transferred air during the procedure is provided. Also provided is a method for hormonally enhancing the uterine wall of a patient either prior to or during the time of ET. Quantitative administration of transfer solutions is accomplished with a modified apparatus that provides for implantation of an embryo into the uterus of a patient. The apparatus comprises an outer sheath and an inner lumen arranged to be slidably disposed within the outer sheath. The inner lumen includes at least one visual marker situated on the exterior surface adjacent its distal end thereof. | 11-05-2015 |
20150335354 | RECOVERY AND PROCESSING OF HUMAN EMBRYOS FORMED IN VIVO - A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus. | 11-26-2015 |
20150342642 | EMBRYO TRANSFER CATHETER AND METHOD - An embryo transfer catheter ( | 12-03-2015 |
20150346187 | In Vitro Embryo Blastocyst Prediction Methods - Methods, compositions and kits for determining the likelihood of reaching the blastocyst stage for one or more embryos or pluripotent cells are provided. These methods, compositions and kits find use in identifying embryos and oocytes in vitro that are most useful in treating infertility in humans. | 12-03-2015 |
20150376652 | GENE EDITING IN THE OOCYTE BY CAS9 NUCLEASES - The present invention relates to a method of producing a non-human, mammalian oocyte carrying a modified target sequence in its genome, the method comprising the steps of introducing into a non-human, mammalian oocyte: (a) a clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated protein 9 (Cas9 protein) or a nucleic acid molecule encoding said Cas9 protein; and (b-i) a target sequence specific CRISPR RNA (crRNA) and a trans-activating crRNA (tracr RNA) or a nucleic acid molecule encoding said RNAs; or (b-ii) a chimaeric RNA sequence comprising a target sequence specific crRNA and tracrRNA or a nucleic acid molecule encoding said RNA; wherein the Cas9 protein introduced in (a) and the RNA sequence(s) introduced in (b-i) or (b-ii) form a protein/RNA complex that specifically binds to the target sequence and introduces a single or double strand break within the target sequence. The present invention further relates to the method of the invention, wherein the target sequence is modified by homologous recombination with a donor nucleic acid sequence further comprising the step: (c) introducing a nucleic acid molecule into the cell, wherein the nucleic acid molecule comprises the donor nucleic acid sequence and regions homologous to the target sequence. The present invention also relates to a method of producing a non-human mammal carrying a modified target sequence in its genome. | 12-31-2015 |
20160008030 | UTERINE LAVAGE FOR EMBRYO RETRIEVAL | 01-14-2016 |
20160030084 | IMPLANTABLE FLUID DELIVERY DEVICES, SYSTEMS, AND METHODS - Devices, systems, and methods for delivering fluid are provided. Devices include a housing configured for intravaginal deployment and retention, at least one reservoir configured to contain a fluid, and a fluid dispensing mechanism configured to dispense the fluid past the cervix and to the uterus of the subject. Methods include intravaginally deploying and retaining a device in the subject, and dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject. | 02-04-2016 |
20160130560 | METHODS FOR IN VITRO MATURATION OF OVARIAN FOLLICLES - The invention relates to methods to be used in the maturation of ovarian follicles and oocytes. More specifically, the invention concerns the use of inhibitors of the phosphatase PTEN, such as oxovanadate and peroxovanadate complexes, in methods for in vitro and in vivo maturation of follicles and oocytes. | 05-12-2016 |
20160130668 | Detection of Lethality Gene for Improved Fertility in Mammals - Oligonucleic acid molecules comprising a SNP site at a position corresponding to position 7480 of the bovine signal transducer and activator of transcription (STAT5A) coding sequence (SEQ ID NO: 1). Also disclosed are an array or a kit comprising the same, a method for detecting the SNPs, a method for progeny testing of mammals, a method for increasing human and non-human mammal pregnancy rate in natural and artificial reproduction processes. Further provided are cattle breeding methods for improved milk production traits. | 05-12-2016 |
20160150766 | ADVANCING GENETIC GAIN IN BOVINE | 06-02-2016 |
20160151090 | RECOVERY AND PROCESSING OF HUMAN EMBRYOS FORMED IN VIVO | 06-02-2016 |
20160374786 | Embryo Transfer - An embryo from a female animal is transferred to another animal by determining presence of an embryo in the uterus of a donor animal by ultra-sonic imaging and inserting an endoscope vaginally into the uterus to a location adjacent the embryo. A tool of the endoscope projects to a position to extract the embryo washed into a container of the tool which is then closed by moving a closure part to enclose the embryo and extracting the endoscope to remove the embryo for transfer to a recipient animal. The fluid into the container can be controlled in pressure to maintain a required pressure generally matching that inside the uterus. | 12-29-2016 |
20170231659 | EMBRYO TRANSFER CATHETERS | 08-17-2017 |